SLC25A17 and head and neck squamous cell carcinoma: Wilcoxon's test indicated that the SLC25A17 high-expression group exhibited a higher TIDE score, suggesting that the increased expression of SLC25A17 might promote immune escape in HNSCC (Fig. 5D).